Zobrazeno 1 - 2
of 2
pro vyhledávání: '"C. Vanessa Díaz-García"'
Autor:
Luis Paz-Ares, Ana Belén Enguita, Jon Zugazagoitia, Jose A. Lopez-Martin, C. Vanessa Díaz-García, Lara Iglesias-Docampo, Santiago Ponce, Juan Antonio Núñez-Sobrino, Elena Prieto-García, María Teresa Agulló-Ortuño
Publikováno v:
Cancer Research. 76:2263-2263
BACKGROUND: Pemetrexed is an effective antineoplastic agent as monotherapy (second line and maintenance setting) or in platinum-based combination regimes (first-line). Pemetrexed inhibits three key enzymes in the folate metabolic pathway: thymidylate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::623b5f63c3e0802f7c3e131dbbe90bb1
https://doi.org/10.1158/1538-7445.am2016-2263
https://doi.org/10.1158/1538-7445.am2016-2263
Autor:
C. Vanessa Díaz-García, Jose A. Lopez-Martin, M. Teresa Agulló-Ortuño, Analia Rodríguez, Hernán Cortés-Funes, Ana Cortijo, Fernando Lopez-Rios, Luis Paz-Ares, Rocio Garcia-Carbonero
Publikováno v:
Cancer Research. 70:3488-3488
Background: Signaling through the insulin-like growth factor 1 receptor (IGF-1R) has been implicated in the resistance to a number of clinically relevant anti-cancer agents. Objective: To assess the direct anti-tumour effects of the IGF-1R monoclonal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b677106c0622e5861a06e47566a0d34e
https://doi.org/10.1158/1538-7445.am10-3488
https://doi.org/10.1158/1538-7445.am10-3488